Trending Topics in Gastroenterology
Explore current gastroenterology questions, clinical answers, and emerging research by topic.
Explore current gastroenterology questions, clinical answers, and emerging research by topic.
T1 Colorectal Cancer (CRC) T1 CRC refers to early-stage colorectal cancer where the tumor has invaded the submucosa but has not yet spread further. It is subdivided into...
The novel therapeutic approach for pancreatic cancer, as detailed in the study published in Gastrointestinal Endoscopy (GIE), January 2026, involves the combination of intratumoral phosphorus-32 (32P) implantation with...
Screening for esophageal cancer is a critical strategy to improve early detection and survival rates, given the disease's poor prognosis due to late-stage diagnosis. However, effective screening approaches...
The study published in Lancet Gastroenterology & Hepatology investigates the efficacy and safety of glecirasib (JAB-21822), a novel covalent small molecule KRASG12C inhibitor, as monotherapy or in combination...
The treatment of hepatobiliary cancers, including hepatocellular carcinoma (HCC) and biliary tract cancer (BTC), is undergoing significant advancements with the development of novel drugs and therapeutic strategies. These...
The tumor microenvironment (TME) in intrahepatic cholangiocarcinoma (iCCA) plays a pivotal role in tumor progression, immune evasion, and therapeutic resistance. iCCA is characterized by a highly complex and...
The Chinese Expert Consensus on Diagnosis and Treatment of Small Gastrointestinal Stromal Tumors (GISTs) is a comprehensive guideline developed by the CSCO Gastrointestinal Stromal Tumor Committee in collaboration...
The title “Chemotherapy for Locally Advanced Pancreatic Cancer After NEOPAN: David vs Goliath” appears to metaphorically frame the debate between different treatment paradigms for locally advanced pancreatic cancer...
The Short-Course Radiotherapy (SCRT) for Older Patients With Locally Advanced Rectal Cancer (SOFT Study) is a multicenter investigation focused on evaluating the effectiveness and feasibility of SCRT followed...
Immune Checkpoint Inhibitor–Induced Diabetes (ICI-D) is a rare yet serious immune-related adverse event that can arise in patients undergoing cancer immunotherapy, specifically in clinical trials involving programmed cell...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.